Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Cytosorbents (CTSO) Cost of Revenue (2016 - 2026)

Cytosorbents filings provide 15 years of Cost of Revenue readings, the most recent being $2.4 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 16.09% to $2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.6 million, a 1.27% decrease, with the full-year FY2025 number at $10.6 million, down 1.27% from a year prior.
  • Cost of Revenue hit $2.4 million in Q4 2025 for Cytosorbents, down from $2.8 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $4.5 million in Q3 2022 to a low of -$9.9 million in Q4 2022.
  • Median Cost of Revenue over the past 5 years was $2.5 million (2023), compared with a mean of $2.1 million.
  • Biggest five-year swings in Cost of Revenue: tumbled 415.68% in 2022 and later soared 123.8% in 2023.
  • Cytosorbents' Cost of Revenue stood at $3.1 million in 2021, then tumbled by 415.68% to -$9.9 million in 2022, then soared by 123.8% to $2.3 million in 2023, then increased by 23.42% to $2.9 million in 2024, then fell by 16.09% to $2.4 million in 2025.
  • The last three reported values for Cost of Revenue were $2.4 million (Q4 2025), $2.8 million (Q3 2025), and $2.8 million (Q2 2025) per Business Quant data.